Decreased CCR5 expression on CD4+ T cells of SIV-infected sooty mangabeys

AIDS Research and Human Retroviruses

Volumn 19, Issue 3, 2003, Pages 227-233

  Veazey, Ronald ^a   Ling, Binhua ^a   Pandrea, Ivona ^a   McClure, Harold ^b   Lackner, Andrew ^a   Marx, Preston ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CERCOCEBUS; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LIFESPAN; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES DIFFERENTIATION; T LYMPHOCYTE; VIRUS LOAD;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CERCOCEBUS ATYS; GENE EXPRESSION; RECEPTORS, CCR5; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0037348515     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203763315731     Document Type: Article

References (38)

1. Gao F, Bailes E, Robertson DL, et al.: Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999;397:436-441.
2. Chakrabarti LA, Lewin SR, Zhang L, et al.: Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J Virol 2000;74:1209-1223.
3. Chen Z, Telfier P, Gettie A, et al.: Genetic characterization of new West African simian immunodeficiency virus SIVsm: Geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop. J Virol 1996;70:3617-3627.
4. Rey-Cuille MA, Berthier JL, Bomsel-Demontoy MC, et al.: Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol 1998;72:3872-3886.
5. Kaur A, Grant RM, Means RE, et al.: Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. J Virol 1998;72:9597-9611.
6. Desrosiers RC: The simian immunodeficiency viruses. Annu Rev Immunol 1990;8:557-578.
7. Mansfield KG, Lerche NW, Gardner MB, and Lackner AA: Origins of simian immunodeficiency virus infection in macaques at the New England Regional Primate Research Center. J Med Primatol 1995;24:116-122.
8. Chen Z, Zhou P, Ho DD, et al.: Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 1997;71:2705-2714.
9. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877.
10. Choe H, Farzan M, Sun Y, et al.: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 199;86:1135-1148.
11. Doranz BJ, Rucker J, Yi Y, et al.: A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-2b as fusion cofactors. Cell 1996;86:1149-1159.
12. Alkhatib G, Combadiere C, Broder CC, et al.: CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
13. Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, et al.: Chemokine control of HIV-1 infection. Nature 1999;400:723-724.
14. Berger EA, Doms RW, Fenyö E-M, et al.: A new classification for HIV-1. Nature 1998;391:240.
15. Marx PA and Chen Z: The function of simian chemokine receptors in the replication of SIV. Semin Immunol 1998;10:215-223.
16. Zhang Y, Lou B, Lal RB, et al.: Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells. J Virol 2000;74:6893-6910.
17. Sallusto F, Lenig D, Mackay CR, and Lanzavecchia A: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875-883.
18. Wu L, Paxton WA, Kassam N, et al.: CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997;185:1681-1691.
19. Liu R, Paxton WA, Choe S, et al.: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-377.
20. Huang Y: The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996;2:175-182.
21. Buseyne F, Janvier G, Teglas JP, et al.: Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age. J Infect Dis 1998;178:1019-1023.
22. Veazey RS, Marx PA, and Lackner AA: The mucosal immune system: Primary target for HIV infection and AIDS. Trends Immunol 2001;22:626-633.
23. + T cells in lymphoid tissues during simian immunodeficiency virus infection. J Virol 2000;74:11001-11007.
24. Harouse JM, Gettie A, Tan RC, et al.: Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 1999;284:816-819.
25. Ameisen JC: From cell activation to cell depletion. In: Cell Activation and Apoptosis in HIV Infection (Andrieu J-M and Lu W, eds.). Plenum Press, New York, 1995, pp. 139-163.
26. Chen Z, Kwon D, Jin Z, et al.: Natural infection of a homozygous Δ24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus. J Exp Med 1998;188:2057-2065.
27. Gerdes J: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-1715.
28. + T ceils correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. J Infect Dis 1998;178:1279-1287.
29. + T lymphocytes in HIV-1 infection as measured by Ki67 antigen. J Exp Med 1998;187:1295-1303.
30. + T lymphocyte turnover in simian immunodeficiency virus-infected macaques. Proc Natl Acad Sci USA 1998;95:6388-6393.
31. Ostrowski MA, Justement SJ, Catanzaro A, et al.: Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J Immunol 1998;161:3195-3201.
32. Mohri H, Bonhoeffer S, Simon M, et al.: Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 1998;279:1223-1227.
33. Fultz PN, Stricker RB, McClure HM, et al.: Humoral response to SIV/SMM infection in macaque and mangabey monkeys. J Acquir Immune Defic Syndr 1990;3:319-329.
34. Christensen D: What activates AIDS? Sci News 2002;161:360-361.
35. + T lymphocytes in HIV-infected patients treated with interleukin-2. ANRS 048 IL-2 Study Group. AIDS 1999;13:455-463.
36. Lee B, Sharron M, Montaner LJ, et al.: Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci USA 1999;96:5215-5220.
37. Finzi D, Hermankova M, Pierson T, et al.: Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997:278:1295-1300.
38. + T cells in HIV-1 infection and response to highly active anti-retroviral therapy. J Acquir Immune Defic Syndr 2001;27:105-115.